Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants
Clinical trial NCT00433914 · COMPLETED
Trial details
- NCT number
- NCT00433914
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2007-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.